Pay in 4 interest-free payments of $6.51 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
The high estrogen also causes FSH production to DECREASE, resulting in poor follicle development
Weight Loss Clinical Trial Results In Phase 2 clinical trials: Participants receiving 12 mg experienced up to 24.2% average body weight loss at 48 weeks Additional studies reported up to 28.7% weight reduction at 68 weeks Higher doses (8 mg and 12 mg) demonstrated the most significant results These findings suggest Retatrutide may outperform current GLP-1 therapies and dual-agonist medications in terms of total weight loss
doi:10.1016/j.yhbeh.2009.10.015 pmid:19900453 Labandeira-Garcia JL, Rodriguez-Perez AI, Valenzuela R, Costa-Besada MA, Guerra MJ (2016) Menopause and Parkinsons disease
Bone Density Enhancement Growth hormone influences bone metabolism by promoting osteoblast activity, which is responsible for bone formation, and inhibiting osteoclast function, which is involved in bone resorption (3)
It may also help to focus on getting the vitamins from food instead, start with a very low dose, and be sure to use a reputable supplement manufacturer
